Logo-ipp

Immunopathol Persa. 2018;4(2): e18. doi: 10.15171/ipp.2018.18

Mini-Review

High prevalence and risk factors of hepatitis B, C and E infections among Middle Eastern countries

Farshad Nojoomi 1, Abdolmajid Ghasemian 1 * , Shahab Fallahi 1, Fatemeh Hasanvand 1

Cited by CrossRef: 1

1- Rashdan H, Hassan S, Maher S, Okasha H. Towards novel liver injury therapies based on design, synthesis and therapeutic efficacy of novel sulfone bis-compound on liver necrosis. Sci Rep. 2025;15(1) [Crossref]
2- Athamneh R, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens. 2021;10(10):1333 [Crossref]